IPO registrations (S-1, F-1) · Registrants

COSCIENS Biopharma Inc.

SEC CIK
1113423 · filings on EDGAR ↗
Name on the registration
Aeterna Zentaris Inc.
Former names
Aeterna Zentaris Inc. (2004–2024); AETERNA LABORATORIES INC (2000–2004)
Registration
Form F-1, first filed 2020-06-08, last 2024-05-14; 4 initial registrations, 3 amendments
Outcome
Final prospectus filed 2020-07-06; declared effective 2020-06-16
Industry (SIC)
Perfumes, Cosmetics & Other Toilet Preparations 2844
Incorporated in
A6
Business address
C/O NORTON ROSE FULBRIGHT CANADA LLP, 222 BAY STREET, SUITE 3000, PO BOX 53, Toronto, A6 M5K 1E7
Ticker
CSCIF (OTC)
EDGAR entity type
other
Insiders and CEO pay
COSCIENS Biopharma Inc. on the corporate pages

Offering terms

Final price
$0.45 per share (424B4 filed 2020-07-06)
Shares sold
17,544,516
Gross proceeds
$7,895,032 before underwriting discounts and any over-allotment option
Listing
TSX under the symbol AEZS
Lead underwriters
H.C. Wainwright
Syndicate
Wainwright & Co; of Contents

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 33

FiledFormWhat it isName as filedEDGAR
2020-06-08F-1F-1 (foreign registration)Aeterna Zentaris Inc.0001493152-20-010765 ↗
2020-06-16EFFECTEFFECT (declared effective)Aeterna Zentaris Inc.9999999995-20-001452 ↗
2020-06-18F-1F-1 (foreign registration)Aeterna Zentaris Inc.0001493152-20-011392 ↗
2020-06-30F-1/AF-1/A (amendment)Aeterna Zentaris Inc.0001493152-20-012272 ↗
2020-07-01EFFECTEFFECT (declared effective)Aeterna Zentaris Inc.9999999995-20-001617 ↗
2020-07-06424B4424B4 (final prospectus)Aeterna Zentaris Inc.0001493152-20-012599 ↗
2020-09-02F-1F-1 (foreign registration)Aeterna Zentaris Inc.0001493152-20-017167 ↗
2020-09-14EFFECTEFFECT (declared effective)Aeterna Zentaris Inc.9999999995-20-002444 ↗
2021-03-30EFFECTEFFECT (declared effective)Aeterna Zentaris Inc.9999999995-21-001194 ↗
2021-03-30EFFECTEFFECT (declared effective)Aeterna Zentaris Inc.9999999995-21-001195 ↗
2021-03-30EFFECTEFFECT (declared effective)Aeterna Zentaris Inc.9999999995-21-001197 ↗
2021-04-06EFFECTEFFECT (declared effective)Aeterna Zentaris Inc.9999999995-21-001304 ↗
2021-04-07EFFECTEFFECT (declared effective)Aeterna Zentaris Inc.9999999995-21-001312 ↗
2021-04-07EFFECTEFFECT (declared effective)Aeterna Zentaris Inc.9999999995-21-001313 ↗
2021-04-07EFFECTEFFECT (declared effective)Aeterna Zentaris Inc.9999999995-21-001314 ↗
2022-05-19EFFECTEFFECT (declared effective)Aeterna Zentaris Inc.9999999995-22-001524 ↗
2022-05-19EFFECTEFFECT (declared effective)Aeterna Zentaris Inc.9999999995-22-001525 ↗
2022-05-19EFFECTEFFECT (declared effective)Aeterna Zentaris Inc.9999999995-22-001526 ↗
2023-05-10EFFECTEFFECT (declared effective)Aeterna Zentaris Inc.9999999995-23-001358 ↗
2023-05-10EFFECTEFFECT (declared effective)Aeterna Zentaris Inc.9999999995-23-001359 ↗
2023-05-10EFFECTEFFECT (declared effective)Aeterna Zentaris Inc.9999999995-23-001360 ↗
2024-02-15F-1F-1 (foreign registration)Aeterna Zentaris Inc.0001493152-24-006882 ↗
2024-04-30F-1/AF-1/A (amendment)Aeterna Zentaris Inc.0001493152-24-017087 ↗
2024-05-14F-1/AF-1/A (amendment)Aeterna Zentaris Inc.0001493152-24-018990 ↗
2024-05-16EFFECTEFFECT (declared effective)Aeterna Zentaris Inc.9999999995-24-001546 ↗
2024-06-04EFFECTEFFECT (declared effective)Aeterna Zentaris Inc.9999999995-24-001724 ↗
2024-06-04EFFECTEFFECT (declared effective)Aeterna Zentaris Inc.9999999995-24-001725 ↗
2024-06-04EFFECTEFFECT (declared effective)Aeterna Zentaris Inc.9999999995-24-001726 ↗
2026-03-18EFFECTEFFECT (declared effective)COSCIENS Biopharma Inc.9999999995-26-000843 ↗
2026-03-18EFFECTEFFECT (declared effective)COSCIENS Biopharma Inc.9999999995-26-000844 ↗
2026-03-18EFFECTEFFECT (declared effective)COSCIENS Biopharma Inc.9999999995-26-000845 ↗
2026-03-18EFFECTEFFECT (declared effective)COSCIENS Biopharma Inc.9999999995-26-000847 ↗
2026-03-18EFFECTEFFECT (declared effective)COSCIENS Biopharma Inc.9999999995-26-000852 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2020-06-30F-1/Aregistration statement14,457,831-TSX AEZS3primary document; shares sentence, cover names 3document ↗
2020-07-06424B4final prospectus$0.4517,544,516$7,895,032TSX AEZS3primary document; price sentence, shares headline, proceeds computed, cover names 3document ↗

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2020-03-02Aeterna Zentaris Inc.Pharmaceuticals$4,500,000$4,500,00031
2019-10-01Aeterna Zentaris Inc.Pharmaceuticals$4,987,500$4,987,50041

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Form D issuerAeterna Zentaris Inc.SCForm D private offeringsCIK (EXACT)
SEC filerCOSCIENS BIOPHARMA INC.SEC filers (EDGAR)CIK (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Perfumes, Cosmetics & Other Toilet Preparations, A6 first:

More with this interest.

In other datasets, the same topic (Health) in A6:

Interests: Perfumes, Cosmetics & Other Toilet Preparations · Health